Todd D. Gould
Laboratory of Molecular Pathophysiology
Mood and Anxiety Disorders Program
National Institute of Mental Health
NIH, HHS, Bethesda
USA
Name/email consistency: high
- Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium. Gould, T.D., O'Donnell, K.C., Picchini, A.M., Manji, H.K. Neuropsychopharmacology (2007)
- Psychiatric endophenotypes and the development of valid animal models. Gould, T.D., Gottesman, I.I. Genes Brain Behav. (2006)
- Targeting glycogen synthase kinase-3 as an approach to develop novel mood-stabilising medications. Gould, T.D. Expert Opin. Ther. Targets (2006)
- Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders. Gould, T.D., Picchini, A.M., Einat, H., Manji, H.K. Curr. Drug. Targets (2006)
- Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Gould, T.D., Manji, H.K. Neuropsychopharmacology (2005)